Trial document



drksid header

  DRKS00028759

Trial Description

start of 1:1-Block title

Title

Survey of side effects after vaccination (Comirnaty, BNT162b2) against COVID-19 in Children below 5 Years in Germany

end of 1:1-Block title
start of 1:1-Block acronym

Trial Acronym

CoVacU5

end of 1:1-Block acronym
start of 1:1-Block url

URL of the Trial

[---]*

end of 1:1-Block url
start of 1:1-Block public summary

Brief Summary in Lay Language

Survey in parents regarding safety and side effects of the mRNA vaccine (BNT162b2 ) against COVID-19 in children below 5 years who were vaccinated (off-label use) in Germany. The aim of this study is to systematically describe potential side effects of the mRNA-vaccine (BNT162b2) in this age group.

end of 1:1-Block public summary
start of 1:1-Block scientific synopsis

Brief Summary in Scientific Language

A retrospective parental survey-based cohort study on mRNA vaccine (BNT162b2) against COVID-19 as off-label use in Germany. The primary aim of the study is to systematically assess parental self-reported symptoms of side-effects and safety of the vaccine.

end of 1:1-Block scientific synopsis
start of 1:1-Block forwarded Data

Do you plan to share individual participant data with other researchers?

No

end of 1:1-Block forwarded Data
start of 1:1-Block forwarded Data Content

Description IPD sharing plan:

Not envisioned due to the short-term organisation of the current study. Statistical analysis plan will be shared at the time of publication of results as a supplementary document.

end of 1:1-Block forwarded Data Content
start of 1:1-Block organizational data

Organizational Data

  •   DRKS00028759
  •   2022/04/05
  •   [---]*
  •   yes
  •   Approved
  •   A2022-0065, Ethik-Kommission an der Medizinischen Fakultät der Universität Rostock
end of 1:1-Block organizational data
start of 1:n-Block secondary IDs

Secondary IDs

  • [---]*
end of 1:n-Block secondary IDs
start of 1:N-Block indications

Health Condition or Problem studied

  •   vaccination side effects
end of 1:N-Block indications
start of 1:N-Block interventions

Interventions/Observational Groups

  •   Children who were below 5 years of age at the timepoint of first COVID-19 vaccination (BNT162b2)
end of 1:N-Block interventions
start of 1:1-Block design

Characteristics

  •   Non-interventional
  •   Observational study
  •   Single arm study
  •   Open (masking not used)
  •   [---]*
  •   Uncontrolled/Single arm
  •   Other
  •   Single (group)
  •   N/A
  •   N/A
end of 1:1-Block design
start of 1:1-Block primary endpoint

Primary Outcome

Symptoms occurring after the first, second or third COVID-19 vaccination (BNT162b2), stratified by dosage used

end of 1:1-Block primary endpoint
start of 1:1-Block secondary endpoint

Secondary Outcome

- Overview of used BNT162b2 vaccine dosage according to age group
- Investigation of risk factors for occurrence of vaccination-related symptoms or side effects
- retrospective estimation of the incidence of COVID-19 diagnosis, -COVID-19-related hospitalisations and complications among the study population

end of 1:1-Block secondary endpoint
start of 1:n-Block recruitment countries

Countries of Recruitment

  •   Germany
end of 1:n-Block recruitment countries
start of 1:n-Block recruitment locations

Locations of Recruitment

  • other 
end of 1:n-Block recruitment locations
start of 1:1-Block recruitment

Recruitment

  •   Actual
  •   2022/04/14
  •   10000
  •   Monocenter trial
  •   National
end of 1:1-Block recruitment
start of 1:1-Block inclusion criteria

Inclusion Criteria

  •   Both, male and female
  •   0   Years
  •   5   Years
end of 1:1-Block inclusion criteria
start of 1:1-Block inclusion criteria add

Additional Inclusion Criteria

-Informed consent of parents legal representatives to allow anonymized web-based survey
- Children below 5 years of age who have received at least one vaccination against SARS-CoV2

end of 1:1-Block inclusion criteria add
start of 1:1-Block exclusion criteria

Exclusion Criteria

- Children older than 5 years of age
- Children without vaccination against SARS-CoV2

end of 1:1-Block exclusion criteria
start of 1:n-Block addresses

Addresses

  • start of 1:1-Block address primary-sponsor
    • Klinik und Poliklinik für Kinder-und Jugendmedizin, Universitätsmedizin Rostock
    • Mr.  PD, MD, PhD  Cho-Ming  Chao 
    • Ernst-Heydemann-Straße 8
    • 18057  Rostock
    • Germany
    end of 1:1-Block address primary-sponsor
    start of 1:1-Block address contact primary-sponsor
    end of 1:1-Block address contact primary-sponsor
  • start of 1:1-Block address scientific-contact
    • Klinik und Poliklinik für Kinder-und Jugendmedizin, Universitätsmedizin Rostock
    • Mr.  PD, MD, PhD  Cho-Ming  Chao 
    • Ernst-Heydemann-Straße 8
    • 18057  Rostock
    • Germany
    end of 1:1-Block address scientific-contact
    start of 1:1-Block address contact scientific-contact
    end of 1:1-Block address contact scientific-contact
  • start of 1:1-Block address public-contact
    • Klinik und Poliklinik für Kinder-und Jugendmedizin, Universitätsmedizin Rostock
    • Mr.  PD, MD, PhD   Cho-Ming  Chao 
    • Ernst-Heydemann-Straße 8
    • 18057  Rostock
    • Germany
    end of 1:1-Block address public-contact
    start of 1:1-Block address contact public-contact
    end of 1:1-Block address contact public-contact
end of 1:n-Block addresses
start of 1:n-Block material support

Sources of Monetary or Material Support

  • start of 1:1-Block address materialSupport
    • Klinik und Poliklinik für Kinder-und Jugendmedizin, Universitätsmedizin Rostock
    • Mr.  PD, MD, PhD  Cho-Ming  Chao 
    • Ernst-Heydemann-Straße 8
    • 18057  Rostock
    • Germany
    end of 1:1-Block address materialSupport
    start of 1:1-Block address contact materialSupport
    end of 1:1-Block address contact materialSupport
end of 1:n-Block material support
start of 1:1-Block state

Status

  •   Recruiting complete, follow-up complete
  •   [---]*
  •   [---]*
  •   2022/05/09
  •   8167
  •   8167
end of 1:1-Block state
start of 1:n-Block publications

Trial Publications, Results and other Documents

end of 1:n-Block publications
* This entry means the parameter is not applicable or has not been set.